Clinical improvement of methicillin-resistant Staphylococcus epidermidis prosthetic knee joint infection after changing therapy from tedizolid to linezolid: A case report.
Yuichi Shibata, Nobuhiro Asai, Taketo Mizuno et al.
✦ AI-curated · Sources linked
Case in brief
A patient with a methicillin-resistant Staphylococcus epidermidis prosthetic knee joint infection experienced worsening symptoms despite revision surgery and prolonged therapy with tedizolid. Clinical improvement was achieved after switching to oral linezolid, with careful dose adjustment to minimize hematological toxicity. The patient maintained effective plasma concentrations and showed sustained improvement without severe side effects.
Diagnostic / clinical pearl
This case highlights the potential benefit of switching from tedizolid to linezolid in cases of methicillin-resistant Staphylococcus epidermidis prosthetic joint infections when initial therapy fails.
Why it matters
The findings underscore the importance of therapeutic drug monitoring in optimizing linezolid dosing to reduce the risk of hematological toxicity during prolonged treatment.